MCCP
AGN

Mission Creek Capital Partners’s Allergan plc AGN Stock Holding History

Mission Creek Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,374
Closed -$243K – 179
2020
Q1 		$243K Hold
1,374
– – 0.13% 147
2019
Q4 		$263K Buy
+1,374
New +$248K 0.12% 164

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Mission Creek Capital Partners's AGN Position: Q2 2020 in Review

Mission Creek Capital Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,374 shares — an estimated $243K sold.

Mission Creek Capital Partners first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $263K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Mission Creek Capital Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Mission Creek Capital Partners sold 1,374 Allergan plc shares in Q2 2020, an estimated $243K.
  • Mission Creek Capital Partners first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Mission Creek Capital Partners's Allergan plc position peaked at $263K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Mission Creek Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.